Bioaffinity Technologies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.85

+0.10 (+13.49%)

As of Feb 8, 2:33 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,235.3% upside

Low Target $22.24

Average Target $28.39

High Target $33.42

Current Price $0.85

Current
$0.85

Target
$28.39

$22.24 $28.39 avg $33.42

Scenario Analysis

Bear Case

$22.24

2,512.8%

Low target

Base Case

$28.39

+3,235.3%

Avg target

Bull Case

$33.42

+3,826.2%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$28.80

-97.0% from high

52-Week Low

$18.12

+-95.3% from low

Target vs 52W High

$28.39

-1.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%